Skip to content
Disclosery

Callan Capital, LLC: GSK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Callan Capital, LLC on GSK, newest first. How the timeline and the estimate are built.

Callan Capital, LLC held 13,401 GSK shares at 2025-03-31 per its 13F-HR filed 2025-04-29.

the latest 13F is the newest step

  1. period ended2025-03-31
    13F 13,401 shares
    Change vs previous 13F +3,714 shares

    0.04% of the 13F portfolio, value $519,155.

    13F-HR 0001542166-25-000005 filed by Callan Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2024-12-31
    13F 9,687 shares
    Change vs previous 13F +2,940 shares

    0.02% of the 13F portfolio, value $327,614.

    13F-HR 0001542166-25-000003 filed by Callan Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-09-30
    13F 6,747 shares
    Change vs previous 13F -151 shares

    0.02% of the 13F portfolio, value $275,817.

    13F-HR 0001542166-24-000015 filed by Callan Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-06-30
    13F/A 6,898 shares
    Change vs previous 13F +985 shares

    0.02% of the 13F portfolio, value $265,573.

    13F-HR/A 0001542166-24-000013 filed by Callan Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-03-31
    13F/A 5,913 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $253,490.

    13F-HR/A 0001542166-24-000011 filed by Callan Capital, LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).